Beijing Tiantan Biological Products Co., Ltd. (SHA:600161)
China · Delayed Price · Currency is CNY 19.71
-0.02 (-0.10%)
Jul 18, 2025, 9:44 AM CST
Beijing Tiantan Biological Products Company Description
Beijing Tiantan Biological Products Co., Ltd. engages in the research and development, manufacture, sale, and marketing of blood products in China and internationlly.
Its products include human albumin; intravenous human immunoglobulin; rabies patient immunoglobulin; tetanus human immunoglobulin; hepatitis B human immunoglobulin; freeze-dried intravenous hepatitis B human immunoglobulin; histamine human immunoglobulin; human prothrombin complex; human coagulation factors VIII; human fibrinogen; recombinant human coagulation factor VIII for injection; and other blood products.
Beijing Tiantan Biological Products Co., Ltd. was founded in 1966 and is headquartered in Beijing, China.
Beijing Tiantan Biological Products Co., Ltd.
| Country | China |
| Founded | 1966 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 5,298 |
| CEO | Yanlin He |
Contact Details
Address: No.B2 Shuangqiao Road Beijing, 100024 China | |
| Phone | 86 10 6543 4018 |
| Website | tiantanbio.com |
Stock Details
| Ticker Symbol | 600161 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE000000WF9 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Hui Chuan Yang | Chairman of the Board |
| Yanlin He | Deputy GM and Director |
| Xiang Ci | General Counsel and Chief Compliance Officer |
| Yana Liu | Deputy GM and Director |
| Hongqing Wang | Chief Financial Officer |